New perspectives on molecular and cellular mechanisms of neuroprotection and neuroregeneration: Part II

Expert Review of Neurotherapeutics

Volumn 10, Issue 8, 2010, Pages 1253-1257

  Sharma, Hari Shanker ^a   Sharma, Aruna ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INDUSTRY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; MEDICAL SOCIETY; MEDICAL SPECIALIST; MOLECULAR MECHANICS; NANOTECHNOLOGY; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; SWEDEN;

CENTRAL NERVOUS SYSTEM DISEASES; DRUG DELIVERY SYSTEMS; DRUG INDUSTRY; HUMANS; NANOMEDICINE; NERVE REGENERATION; NEUROPROTECTIVE AGENTS;

EID: 77955071497     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.78     Document Type: Conference Paper

References (15)

1. Sharma HS, Sharma A. New perspectives on molecular and cellular mechanisms of neuroprotection and neuroregeneration: part I. Expert Rev. Neurother. 10(7), 1039-1043 (2010)
2. Strekalova T, Steinbusch HWM. Measuring behavior in mice with chronic stress depression paradigm. Prog. Neuropsychopharmacol. Biol. Psychiatry 34(2), 348-361 (2010).
3. Sierksma AS, van den Hove DL, Steinbusch HW, Prickaerts J. Major depression, cognitive dysfunction and Alzheimer's disease: is there a link? Eur. J. Pharmacol. 626, 72-82 (2010).
4. Oxenkrug GF. Kynurenine/pteridines hypothesis of aging, metabolic syndrome and related aging-associated disorders. J. Neural Transm. (2010) (In press).
5. Flood JF, Morley JE. Learning and memory in the SAMP8 mouse. Neurosci. Biobehav. Rev. 22, 1-20 (1998).
6. Poon HF, Farr SA, Banks WA et al. Proteomic identifcation of less oxidized brain proteins in aged senescence accelerated mice following administration of antisense oligonucleotide directed at the Ap region of amyloid precursor protein. Brain Res. Mol. Brain Res. 138, 8-16 (2005).
7. Bulka A, Kouya PF, Böttiger Y, Svensson A-O, Xu X-J, Wiesenfeld-Hallin Z. Comparison of the antinociceptive effects of morphine, methadone, buprnorphine and codeine in two substrains of Sprague-Dawley rats. Eur. J. Pharmacol. 492, 27-34 (2004).
8. Carlsson A, Ohsawa M, Hallberg M, Nyberg F, Kamei J. Substance P induces antihyperalgesia in diabetic mice through a mechanism involving the naloxone-sensitive sigma receptors Eur. J. Pharmacol. 626, 250-255 (2010).
9. Nyberg F. The role of the somatotrophic axis in neuroprotection and neuroregeneration of the addictive brain. Int. Rev. Neurobiol. 88, 399-427 (2009).
10. Ehrenreich H, Siren AL. Neuroprotection-What does it mean?-What means do we have? Eur. Arch. Psychiatry Clin. Neurosci. 251, 149-151 (2001).
11. Gordon CJ. Cardiac and thermal homeostasis in the aging Brown Norway rat. J. Gerontol. A Biol. Sci. Med. Sci. 63(12), 1307-1313 (2008).
12. Leon LR, DuBose DA, Mason CD. Heat stress induces a biphasic thermoregulatory response in mice. Am. J. Physiol. 288, R197-R204 (2005).
13. Sharma HS. Neurotrophic factors in combination: a possible new therapeutic strategy to infuence pathophysiology of spinal cord injury and repair mechanisms. Curr. Pharm. Des. 13(18), 1841-1874 (2007).
14. Sharma HS, Winkler T, Stålberg E, Olsson Y, Dey PK. Evaluation of traumatic spinal cord edema using evoked potentials recorded from the spinal epidural space. An experimental study in the rat. J. Neurol. Sci. 102(2), 150-162 (1991).
15. Sharma HS. New perspectives for the treatment options in spinal cord injury. Expert Opin. Pharmacother. 9(16), 2773-2800 (2008).